Subscribe to RSS
DOI: 10.1055/s-0028-1088197
β-Nitroacrylates as Key Starting Materials for the Uncatalysed One-Pot Synthesis of Polyfunctionalized Dihydroquinoxalinone Derivatives, via an anti-Michael Reaction
Publication History
Publication Date:
16 March 2009 (online)
Abstract
The reaction of o-phenylenediamine with β-nitroacrylates allows the in situ preparation of dihydroquinoxalinones, via an anti-Michael reaction, under uncatalysed reaction conditions.
Key words
β-nitroacrylates - anti-Michael reaction - uncatalysed - quinoxalinones
- Review:
-
1a
Porter AE. In Comprehensive Heterocyclic Chemistry Vol 3:Katritzky AR.Rees CW. Pergamon; Oxford: 1984. p.157 -
1b
Sato N. In Comprehensive Heterocyclic Chemistry II Vol. 6:Katritzki AR.Rees CW.Scriven EFV. Pergamon; Oxford: 1996. p.233 -
1c
Sakata G.Makino K.Kurasama Y. Heterocycles 1988, 27: 2481 -
1d
Cheeseman GWH.Werstiuk ESG. Adv. Heterocycl. Chem. 1978, 22: 367 - 2
Horton DA.Bourne GT.Smythe ML. Chem. Rev. 2003, 103: 893 - 3
Gupta D.Ghosh NN.Chandra R. Bioorg. Med. Chem. Lett. 2005, 15: 1019 - 4
Rösner M,Billhardt-Troughton U.-M,Kirsh R,Keim J.-P,Meichsner C,Riess G, andWinkler I. inventors; US 5,723,461. -
5a
Sarges R.Lyga JW. J. Heterocycl. Chem. 1988, 25: 1475 -
5b
Bunin BA.Ellman JA. J. Am. Chem. Soc. 1992, 114: 10997 - 6
Lee L.Murray WV.Rivero RA. J. Org. Chem. 1997, 62: 3874 - 7
Morales GA.Corbett JW.DeGrado WF. J. Org. Chem. 1998, 63: 1172 - 8
Jones Z,Groneberg R,Drew M, andEary CT. inventors; US 20050282812. -
9a
Lee J.Murray WV.Rivero RA. J. Org. Chem. 1997, 62: 3874 -
9b
Zaragoza F.Stephensen H. J. Org. Chem. 1999, 64: 2555 - See for example:
-
10a
Acharya AN.Ostresh JM.Houghten RA. Tetrahedron 2002, 58: 221 -
10b
Atrash B.Bradley M.Kobylecki R.Cowell D.Reader J. Angew. Chem. Int. Ed. 2001, 40: 938 -
10c
Jiang Q.Jiang D.Jiang Y.Fu H.Zhao Y. Synlett 2007, 1836 -
10d
Chicharro R.de Castro S.Reino JL.Arán VJ. Eur. J. Org. Chem. 2003, 23146 -
10e
Mahaney PE.Webb MB.Ye F.Sabatucci JP.Steffan RJ.Chadwick CC.Harnish DC.Trybulski EJ. Bioorg. Med. Chem. 2006, 14: 3455 - 11
Suschitzky H.Wakefield BJ.Whittaker RA. J. Chem. Soc., Perkin Trans. 1 1975, 401 - See, for example:
-
12a
Kim KS.Qian L.Bird JE.Dickinson KEJ.Moreland S.Schaeffer TR.Waldron TL.Delaney CL.Weller HN.Miller AV. J. Med. Chem. 1993, 36: 2335 -
12b
Kim Y.Lee MH.Choi ET.No ES.Park YS. Heterocycles 2007, 71: 5 -
12c
Kamila S.Biehl ER. Heterocycles 2006, 68: 1931 -
12d
Kim Y.Kang KH.Choi ET.Lee MH.Park YS. Bull. Korean Chem. Soc. 2007, 28: 325 - 13
El-Maati TMA. Bull. Chim. Farm. 1999, 138: 272 - 14
Murata S.Sugimoto T.Matsuura S. Heterocycles 1987, 26: 883 - 15
Ballini R.Fiorini D.Palmieri A. Tetrahedron Lett. 2004, 45: 7027 - 16
Ballini R.Gabrielli S.Palmieri A.Petrini M. Tetrahedron 2008, 64: 5435 - 17
Ballini R.Bazán NA.Bosica G.Palmieri A. Tetrahedron Lett. 2008, 49: 3865 - 18
Ballini R.Fiorini D.Palmieri A. Tetrahedron Lett. 2005, 46: 1245 -
19a
Seebach D.Colvin EW.Lehr F.Weller T. Chimia 1979, 33: 1 -
19b
Rosini G.Ballini R. Synthesis 1988, 833 -
19c
Ono N. The Nitro Group in Organic Synthesis Wiley; New York: 2001. -
19d
Ballini R.Petrini M. Tetrahedron 2004, 60: 1017 - 20
Ballini R.Bosica G.Fiorini D.Palmieri A.Petrini M. Chem. Rev. 2005, 105: 933
References and Notes
Typical Procedure
for the Conjugate Addition of Active Methylene 5 to β-Nitroacrylates
1
β-Nitroacrylate 2 (1
mmol) and o-phenylenediamine 1 (1.25 mmol) were dissolved in EtOAc (2
mL) and mixed at r.t., with magnetic stirring, for 2 h. Then, acetone
(2 mL, in order to increase the solubility of 4)
and 0.8 g of SiO2 (Silica Gel 60, 0,040-0,063
mm, 230-400 mesh ASTM, Merck), were added and the mixture
was stirred for 5 min. Finally, the solvent was removed under vacuum
and the crude product (adsorbed on SiO2) was charged
onto a chromatography column (cyclohexane-EtOAc) allowing
the pure products 4.
Spectroscopic
Data for Representative Compounds
Compound 4b (diastereomeric mixture): yellow solid.
IR (KBr): ν = 1362, 1546, 1686, 3049, 3414 cm-¹. ¹H
NMR (400 MHz, acetone): δ = 0.95 (t, 3 H, J = 7.3 Hz),
1.88-2.02 (m, 1 H), 2.07-2.25 (m, 1 H), 4.39 (dd,
0.27 H, J = 3.4,
6.8 Hz), 4.62 (dd, 0.73 H, J = 2.6,
4.3 Hz), 4.76-4.84 (m, 0.27 H), 4.88-4.97 (m,
0.73 H), 5.68 (br s, 0.73 H), 5.81 (br s, 0.27 H), 6.66-6.76
(m, 1 H), 6.79-6.92 (m, 3 H), 9.65 (br s, 1 H). ¹³C
NMR (100 MHz, acetone): δ = 10.6, 10.8, 23.1, 24.1,
59.4, 59.8, 90.3, 91.5, 114.9, 115.6, 116.0, 116.1, 119.8, 119.9,
124.4, 124.5, 126.0, 126.3, 132.7, 133.4, 163.6, 164.2. API-ES: m/z = 258.2 [M + Na+].
Anal. Calcd for C1
1H13N3O3 (235.24):
C, 56.16; H, 5.57; N, 17.86. Found: C, 56.44; H, 5.71; N, 17.71.
Compound 4d (diastereomeric mixture): yellow solid.
IR (KBr): ν = 1363, 1544, 1677, 1735, 3067, 3397
cm-¹. ¹H NMR (400
MHz, acetone): δ = 1.26-1.48 (m, 2 H),
1.51-1.70 (m, 2 H), 1.86-2.02 (m, 1 H), 2.07-2.25
(m, 1 H), 2.26-2.35 (m, 2 H), 3.58 (s, 1.5 H), 3.59 (s,
1.5 H), 4.41 (dd, 0.5 H, J = 3.0,
6.8 Hz), 4.64 (dd, 0.5 H, J = 2.6,
4.3 Hz), 4.85-4.93 (m, 0.5 H), 4.99-5.06 (m, 0.5
H), 5.67 (br s, 0.5 H), 5.82 (br s, 0.5 H), 6.67-6.74 (m,
1 H), 6.78-6.91 (m, 3 H), 9.64 (br s, 1 H). ¹³C
NMR (100 MHz, acetone): δ = 24.9, 25.0, 26.0,
26.1, 29.4, 30.3, 33.8, 33.9, 51.6, 59.4, 59.9, 88.7, 89.7, 114.9,
115.5, 116.0, 116.1, 119.8, 119.9, 124.3, 124.4, 126.0, 126.2, 132.6,
133.4, 163.7, 164.1, 173.8, 173.9.
API-ES: m/z = 344.4 [M + Na+].
Anal. Calcd for C15H19N3O5 (321.33):
C, 56.07; H, 5.96; N, 13.08. Found: C, 56.38; H, 6.18; N, 12.81.
Compound 4e (diastereomeric mixture): yellow solid.
IR (KBr): ν = 1361, 1544, 1679, 3059, 3397 cm-¹. ¹H
NMR (400 MHz, acetone): δ = 2.18-2.32
(m, 1 H), 2.40-2.55 (m, 1 H), 2.59-2.74 (m, 2
H), 4.49 (dd, 0.35 H, J = 3.0,
6.8 Hz), 4.66 (dd, 0.65 H, J = 2.6,
4.3 Hz), 4.91-4.98 (m, 0.35 H), 4.99-5.05 (m,
0.65 H), 5.74 (br s, 0.65 H), 5.86 (br s, 0.35 H), 6.65-6.73
(m, 1 H), 6.78-6.90 (m, 3 H), 7.11-7.32 (m, 5 H),
9.67 (br s, 1 H). ¹³C NMR (100 MHz,
acetone): δ = 31.6, 32.5, 32.6, 32.7, 59.6, 60.0,
88.1, 89.5, 114.9, 115.4, 116.0, 116.1, 119.8, 119.9, 124.4, 124.5,
125.9, 126.1, 127.1, 129.2, 129.3, 129.4, 129.5, 132.6, 133.2, 141.1,
141.3, 163.7, 164.0. API-ES: m/z = 334.4 [M + Na+].
Anal. Calcd for C17H17N3O3 (311.34):
C, 65.58; H, 5.50; N, 13.50. Found: C, 65.84; H, 5.73; N, 13.23.
Compound 4f (diastereomeric mixture): yellow solid.
IR (KBr): ν = 1040, 1376, 1553, 1683, 3051, 3389
cm-¹. ¹H NMR (400
MHz, acetone): δ = 1.21-1.26 (m, 3 H),
2.21 (dd, 0.75 H, J = 1.7,
15.4 Hz), 2.38 (dd, 0.25 H, J = 2.6,
15.4 Hz), 2.64-2.79 (m, 1 H), 3.71-3.96 (m, 4
H), 4.33 (dd, 0.25 H, J = 3.0,
7.3 Hz), 4.50 (dd, 0.75 H, J = 2.6,
4.3 Hz), 4.89-4.96 (m, 0.25 H), 5.06-5.13 (m,
0.75 H), 5.66 (br s, 0.75 H), 5.82 (br s, 0.25 H), 6.67-6.76
(m, 1 H), 6.79-6.91 (m, 3 H), 9.67 (br s, 1 H). ¹³C
NMR (100 MHz, acetone): δ = 24.3, 24.4, 38.4,
39.0, 60.1, 60.3, 65.4, 65.5, 84.1, 85.7, 108.5, 114.9, 115.7, 115.9,
116.0, 116.1, 119.8, 119.9, 124.4, 124.5, 125.9, 126.0, 132.4, 132.9,
163.4, 163.5. API-ES: m/z = 330.4 [M + Na+ ].
Anal. Calcd for C14H17N3O5 (307.30):
C, 54.72; H, 5.58; N, 13.67. Found: C, 54.36; H, 5.31; N, 13.83.